For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Influvac | Trivalent influenza subunit vaccine Influvac. "3x 15mcg HA per 0.5 ml,trivalent one injection at Day 1 " | None | None | 0 | 120 | 19 | 120 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| vaccine site pain | None | General disorders | None | View |
| nasal congestion | None | Respiratory, thoracic and mediastinal disorders | None | View |
| oropharyngeal pain | None | Respiratory, thoracic and mediastinal disorders | None | View |
| application site pruritus | None | General disorders | None | View |
| cough | None | Respiratory, thoracic and mediastinal disorders | None | View |
| fatigue | None | General disorders | None | View |
| malaise | None | General disorders | None | View |
| vaccination site warmth | None | General disorders | None | View |
| nasopharyngitis | None | Respiratory, thoracic and mediastinal disorders | None | View |
| respiratory disorder | None | Respiratory, thoracic and mediastinal disorders | None | View |
| vomiting | None | Gastrointestinal disorders | None | View |
| Hyperhidrosis | None | Skin and subcutaneous tissue disorders | None | View |
| headache | None | Nervous system disorders | None | View |
| respiratory tract infection | None | Respiratory, thoracic and mediastinal disorders | None | View |